Stock 600222 HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Henan Taloph Pharmaceutical Stock Co.,Ltd

Equities

600222

CNE0000010L8

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
4.34 CNY +0.46% Intraday chart for Henan Taloph Pharmaceutical Stock Co.,Ltd +2.84% -29.20%
Apr. 25 Henan Taloph Pharmaceutical Stock Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on February 2, 2024. CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Henan Taloph Pharmaceutical Stock Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on February 2, 2024.
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd announces an Equity Buyback for CNY 60 million worth of its shares.
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd authorizes a Buyback Plan.
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Taloph Pharmaceutical Gets Nod to Amend License of Three Products
MT
Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback announced on July 15, 2022, has closed with 14,523,100 shares, representing 2.57% for CNY 79.72 million.
CI
Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.
CI
Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd announces an Equity Buyback for CNY 80 million worth of its shares.
CI
Henan Taloph Pharmaceutical Stock Co.,Ltd authorizes a Buyback Plan.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600222 Stock
  4. News Henan Taloph Pharmaceutical Stock Co.,Ltd
  5. Highlights